ADP-ribosylation of DNA and RNA.


Journal

DNA repair
ISSN: 1568-7856
Titre abrégé: DNA Repair (Amst)
Pays: Netherlands
ID NLM: 101139138

Informations de publication

Date de publication:
09 2021
Historique:
received: 18 03 2021
revised: 28 05 2021
accepted: 31 05 2021
pubmed: 12 6 2021
medline: 13 10 2021
entrez: 11 6 2021
Statut: ppublish

Résumé

ADP-ribosylation is a chemical modification of macromolecules found across all domains of life and known to regulate a variety of cellular processes. Notably, it has a well-established role in the DNA damage response. While it was historically known as a post-translational modification of proteins, recent studies have shown that nucleic acids can also serve as substrates of reversible ADP-ribosylation. More precisely, ADP-ribosylation of DNA bases, phosphorylated DNA ends and phosphorylated RNA ends have been reported. We will discuss these three types of modification in details. In a variety of bacterial species, including Mycobacterium tuberculosis, ADP-ribosylation of thymidine has emerged as the mode of action of a toxin-antitoxin system named DarTG, with the resultant products perceived as DNA damage by the cell. On the other hand, mammalian DNA damage sensors PARP1, PARP2 and PARP3 were shown to ADP-ribosylate phosphorylated ends of double-stranded DNA in vitro. Additionally, TRPT1 and several PARP enzymes, including PARP10, can add ADP-ribose to the 5'-phosphorylated end of single-stranded RNA in vitro, representing a novel RNA capping mechanism. Together, these discoveries have led to the emergence of a new and exciting research area, namely DNA and RNA ADP-ribosylation, that is likely to have far-reaching implications for the fields of DNA repair, replication and epigenetics.

Identifiants

pubmed: 34116477
pii: S1568-7864(21)00100-2
doi: 10.1016/j.dnarep.2021.103144
pmc: PMC8385414
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0
Proto-Oncogene Proteins 0
RNA 63231-63-0
DNA 9007-49-2
PARP1 protein, human EC 2.4.2.30
PARP10 protein, human EC 2.4.2.30
PARP2 protein, human EC 2.4.2.30
PARP3 protein, human EC 2.4.2.30
Poly (ADP-Ribose) Polymerase-1 EC 2.4.2.30
Poly(ADP-ribose) Polymerases EC 2.4.2.30

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103144

Subventions

Organisme : Wellcome Trust
ID : 210634
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R007195/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C35050/A22284
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 210634
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101794
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Références

Nat Commun. 2013;4:2164
pubmed: 23917065
Nature. 2016 Jul 21;535(7612):444-7
pubmed: 27383794
Nucleic Acids Res. 2016 Nov 2;44(19):9279-9295
pubmed: 27471034
Curr Genet. 2019 Oct;65(5):1141-1144
pubmed: 31049660
Toxicon. 2013 Mar 1;63:55-63
pubmed: 23212047
J Biol Chem. 2007 Mar 30;282(13):9469-9474
pubmed: 17276982
Cell Rep. 2018 Aug 28;24(9):2493-2505.e4
pubmed: 30157440
Biochem J. 1999 Sep 1;342 ( Pt 2):249-68
pubmed: 10455009
DNA Repair (Amst). 2014 Nov;23:4-16
pubmed: 24865146
Elife. 2018 Feb 26;7:
pubmed: 29480802
Cold Spring Harb Perspect Biol. 2014 Aug 07;6(9):a016428
pubmed: 25104768
Biochem J. 2015 Jun 1;468(2):293-301
pubmed: 25789582
Nat Struct Mol Biol. 2013 Apr;20(4):508-14
pubmed: 23474712
Science. 1993 Jul 9;261(5118):206-8
pubmed: 8392224
Mol Microbiol. 2020 Oct;114(4):641-652
pubmed: 32634279
Nat Rev Mol Cell Biol. 2012 Jun 20;13(7):411-24
pubmed: 22713970
Sci Rep. 2020 Feb 28;10(1):3699
pubmed: 32111879
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1103-8
pubmed: 15279798
Nat Commun. 2013;4:1683
pubmed: 23575687
Cell Rep. 2020 Feb 4;30(5):1373-1384.e4
pubmed: 32023456
Mol Cell. 2016 Dec 15;64(6):1109-1116
pubmed: 27939941
J Biol Chem. 1997 May 2;272(18):11895-901
pubmed: 9115250
Viruses. 2020 Mar 31;12(4):
pubmed: 32244383
Mol Cell. 2015 Dec 3;60(5):755-768
pubmed: 26626480
J Virol. 2014 Feb;88(4):2116-30
pubmed: 24335297
Nucleic Acids Res. 2011 Sep 1;39(16):6986-97
pubmed: 21596788
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13652-7
pubmed: 16945908
Cell Rep. 2020 Sep 22;32(12):108176
pubmed: 32966781
J Am Chem Soc. 2009 Oct 14;131(40):14258-60
pubmed: 19764761
J Proteome Res. 2013 Apr 5;12(4):1868-80
pubmed: 23438649
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12414-9
pubmed: 11592983
FEBS J. 2017 Dec;284(23):4002-4016
pubmed: 29054115
Nat Chem Biol. 2016 Dec;12(12):998-1000
pubmed: 27723750
Nucleic Acids Res. 2019 Jun 20;47(11):5658-5669
pubmed: 31216043
FEBS J. 2021 Apr;288(7):2131-2142
pubmed: 32785980
Mutat Res Rev Mutat Res. 2019 Apr - Jun;780:82-91
pubmed: 31395352
Nucleic Acids Res. 2019 Dec 2;47(21):11250-11267
pubmed: 31566235
Nat Commun. 2018 Feb 27;9(1):844
pubmed: 29487285
Nature. 2020 Sep;585(7826):609-613
pubmed: 32939087
Semin Cell Dev Biol. 2017 Mar;63:92-101
pubmed: 27670719
Nat Rev Mol Cell Biol. 2017 Aug;18(8):495-506
pubmed: 28512351
J Virol. 2012 Aug;86(15):8147-60
pubmed: 22623789
Mol Cell. 2015 Jun 18;58(6):935-46
pubmed: 26091342
DNA Repair (Amst). 2018 Nov;71:177-182
pubmed: 30177435
Chromosoma. 2014 Mar;123(1-2):79-90
pubmed: 24162931
Front Cell Dev Biol. 2020 Sep 09;8:564601
pubmed: 33015058
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):480-485
pubmed: 28031484
Biochem Soc Trans. 2018 Dec 17;46(6):1681-1695
pubmed: 30420415
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14136-41
pubmed: 9826666
N Engl J Med. 2009 Oct 8;361(15):1475-85
pubmed: 19812404
EMBO J. 2013 May 2;32(9):1225-37
pubmed: 23481255
Nucleic Acids Res. 2017 Aug 21;45(14):8129-8141
pubmed: 28854736
Elife. 2018 May 29;7:
pubmed: 29809136
Genes Dev. 2020 Mar 1;34(5-6):263-284
pubmed: 32029451
Nat Struct Mol Biol. 2004 Jun;11(6):503-11
pubmed: 15164008
Sci Rep. 2016 Oct 06;6:34487
pubmed: 27708353
Sci Rep. 2018 Mar 8;8(1):4176
pubmed: 29520010
Crit Rev Biochem Mol Biol. 2018 Feb;53(1):64-82
pubmed: 29098880
Nucleic Acids Res. 2018 Oct 12;46(18):9617-9624
pubmed: 30202863
Nature. 2006 Oct 12;443(7112):713-6
pubmed: 16964241
Cold Spring Harb Perspect Biol. 2013 Mar 01;5(3):a012591
pubmed: 23457260
Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10608-13
pubmed: 10485873
PLoS Pathog. 2016 Mar 24;12(3):e1005453
pubmed: 27010460
Annu Rev Microbiol. 2012;66:103-23
pubmed: 22994490
Mol Cell. 2015 Dec 3;60(5):742-754
pubmed: 26626479
Nature. 2020 Mar;579(7800):598-602
pubmed: 32028527
Nat Methods. 2013 Oct;10(10):981-4
pubmed: 23955771
mBio. 2017 Jan 17;8(1):
pubmed: 28096490
Mol Cell. 2017 Mar 2;65(5):932-940.e6
pubmed: 28190768
Front Cell Dev Biol. 2020 Nov 26;8:606596
pubmed: 33324653
Annu Rev Biochem. 2016 Jun 2;85:431-54
pubmed: 26844395
DNA Repair (Amst). 2014 Jul;19:14-26
pubmed: 24780558
Mol Cell. 2006 Jul 21;23(2):155-60
pubmed: 16857582
Nat Commun. 2014 Jul 21;5:4426
pubmed: 25043379
J Biol Chem. 2016 May 20;291(21):11198-215
pubmed: 27002155
Elife. 2017 Jun 26;6:
pubmed: 28650317
FEBS J. 2017 Sep;284(18):2932-2946
pubmed: 28383827
Open Biol. 2020 Nov;10(11):200237
pubmed: 33202171
Chem Rev. 2018 Feb 14;118(3):1092-1136
pubmed: 29172462
Science. 2012 May 11;336(6082):728-32
pubmed: 22582261
FEBS J. 2013 Mar;280(5):1330-43
pubmed: 23305266
Nucleic Acids Res. 2018 Mar 16;46(5):2417-2431
pubmed: 29361132
DNA Repair (Amst). 2015 Aug;32:149-157
pubmed: 25957489
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2226-31
pubmed: 11226221
DNA Repair (Amst). 2014 Jul;19:108-13
pubmed: 24755000
Nature. 2015 Mar 19;519(7543):374-7
pubmed: 25533955
Mol Cell. 2016 May 5;62(3):432-442
pubmed: 27067600
Nucleic Acids Res. 2014 Jul;42(12):7762-75
pubmed: 24928857
Cell. 2017 Mar 9;168(6):1015-1027.e10
pubmed: 28283058
Trends Biochem Sci. 2010 Apr;35(4):208-19
pubmed: 20106667
mBio. 2016 Dec 13;7(6):
pubmed: 27965448
PLoS One. 2013 Apr 23;8(4):e60539
pubmed: 23637752

Auteurs

Joséphine Groslambert (J)

Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.

Evgeniia Prokhorova (E)

Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom.

Ivan Ahel (I)

Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom. Electronic address: ivan.ahel@path.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH